2.3. Screening 83 2.3. 1. Population screening for AAA in men 83 2.3. 1.1. The benefits of
ultrasonographic screening for AAA in older persons 83 2.3. 1.2. Harms, benefits and …

Abdominal aortic aneurysms (AAAs) usually expand asymptomatically until the occurrence
of a life-threatening event such as aortic rupture, which is closely associated with high …

Background: Abdominal aortic aneurysm (AAA), if left untreated, poses the main risks of
progressive expansion, rupture, and hemorrhage, leading to death. Large AAA with a risk of …

El aneurisma aórtico abdominal (AAA) es una dilatación progresiva localizada en la aorta
abdominal, que se asocia a una elevada tasa de mortalidad. Su fisiopatología es compleja …

Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

The aorta-on-a-chip (AoOC) is a micro-engineered 3D in vitro model which aims to mimic
the in vivo complexity of a human aorta in terms of cell-cell interaction, tissue architecture …

Thoracic aortic aneurysms are correlated with significant mortality and morbidity. No therapy,
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …

Clinical knowledge pertaining to the prevention of the development and rupture of
abdominal aortic aneurysm (AAA) is essential in daily medical practice, given the significant …

Abdominal aortic aneurysms (AAA) are a major cause of death. Currently, the mainstay of
treatment for AAA is surgical repair and there are no FDA approved medical therapies for …

Abdominal aortic aneurysm (AAA) is a complex pathology with a high mortality rate (around
80%)(Brown et al., 2012) due to its complication, AAA rupture, which is why timely treatment …